Daniel O. Persky MD

Assistant Professor of Medicine (Hematology)

Departments & Organizations

Yale Medical Group

Hematology Program

Hematology

Medical Oncology

Research Interests

Clinical trials, lymphoma, translational research, diffuse large B-cell lymphoma more...

Education

• AB, Harvard University, 1996
• M.D., Albert Einstein College of Medicine, 2000

Selected Publications

• Persky DO, Unger JM, Spier CM, Stea B, LeBlanc M, McCarty MJ, Rimsza LM, Fisher RI, and Miller TP. Effect of Adding Rituximab to Three Cycles of CHOP Plus Involved-Field Radiotherapy for Patients with Limited Stage Aggressive B-Cell Lymphoma. A Southwest Oncology Group Study 0014. J Clin Oncol 2008 May 10;26(14):2258-63. Epub 2008 Apr 14.
• Rimsza LM, Leblanc ML, Unger JM, Miller TP, Grogan TM, Persky DO, Martel RR, Sabalos CM, Seligmann B, Braziel RM, Campo E, Rosenwald A, Connors JM, Sehn LH, Johnson N, Gascoyne RD. Gene expression predicts overall survival in paraffin embedded tissues of diffuse large B cell lymphoma treated with R-CHOP. Blood 2008 Oct 15; 112(8):3425-33. Epub 2008 Jun 10.
• Persky DO, Moskowitz, CH, Filatov A, Saxena R, Haiyan C, Teruya-Feldstein. J. High dose Chemoradiotherapy and ASCT May Overcome the Prognostic Importance of Biologic Markers in Relapsed/Refractory Hodgkin’s Lymphoma. Appl Immunohistochem Mol Morphol 2010 Jan;18(1):35-40.

more...